WHO ICTRP trial

Research on the effect of UHA Gummy Supplement Iron intake on anemia symptoms…

JPRN-jRCT1071230010 · Japan Primary Registries Network (JPRN) · Recruiting

Key facts

Trial ID JPRN-jRCT1071230010
Public title Research on the effect of UHA Gummy Supplement Iron intake on anemia symptoms (UHA-IRON-GS)
Scientific title Research on the effect of UHA Gummy Supplement Iron intake on anemia symptoms and the effect of formulation on convenience of intake and continuity of intake - UHA-IRON-GS
Primary sponsor Takemoto Yuji
Secondary sponsors UHA Mikakuto Co.,Ltd.
Registry Japan Primary Registries Network (JPRN)
Recruitment status Recruiting
Study type Interventional
Conditions anaemia anaemia,Iron prescription;D000740;anaemia,Iron prescription
Interventions 1. UHA Gummy Supplement Iron (iron-containing gummy pills) UHA Gummy Supplement Iron will be consumed daily after breakfast (or approximately at breakfast time if breakfast is not consumed) for 90 days. 2. Control food 1 (Iron-free gummy…
Registration date Apr 19, 2023
Target size 150
Registry page jrct.niph.go.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations